Evidence map›Paper›PMID 29657030›Full record

ArticleCell metabolism2018

Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.

Qiuying Chen, Kathryne Kirk, Yevgeniya I Shurubor, Dazhi Zhao, Andrea J Arreguin, Ifrah Shahi, Federica Valsecchi, Guido Primiano, Elizabeth L Calder, Valerio Carelli and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 1 synthesis or guideline pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Glutamine Metabolism in Cardiac Hypertrophy.Reviews in cardiovascular medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Qiuying ChenDepartment of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Kathryne KirkFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Yevgeniya I ShuruborFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Dazhi ZhaoFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Andrea J ArreguinFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Ifrah ShahiFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Federica ValsecchiFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Guido PrimianoInstitute of Neurology, Catholic University of the Sacred Heart, Rome, Italy.
Elizabeth L CalderCenter for Stem Cell Biology and Developmental Biology Program, Sloan-Kettering Institute for Cancer Research, New York, NY 10065, USA.
Valerio CarelliIRCCS, Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy; Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Travis T DentonDepartment of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA 99210, USA.
M Flint BealFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Steven S GrossDepartment of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Giovanni ManfrediFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: gim2004@med.cornell.edu.
Marilena D'AurelioFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: mad2003@med.cornell.edu.
Weill Cornell Medicine · USMIND Research Institute · USCornell University · USKettering University · USUniversità Cattolica del Sacro Cuore · ITUniversity of Bologna · ITWashington State University Spokane · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Risk Genes and Environment Interactions in NTDsP01HD067244 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSS, MARGARET ELIZABETH · 2011 to 2020
$12.6M
Modulation of Oxidative phosphorylation by mitochondrial soluble adenylyl cyclaseR01GM088999 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI MANFREDI, GIOVANNI · 2009 to 2014
$2.1M
Impaired amino acid metabolism in mitochondrial diseasesR21NS084524 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI MANFREDI, GIOVANNI · 2013 to 2014
$464k
NCI NIH HHS P30 CA008748NICHD NIH HHS P01 HD067244NIGMS NIH HHS R01 GM088999NINDS NIH HHS R21 NS084524
6 · The paper itself

Abstract

Using molecular, biochemical, and untargeted stable isotope tracing approaches, we identify a previously unappreciated glutamine-derived α-ketoglutarate (αKG) energy-generating anaplerotic flux to be critical in mitochondrial DNA (mtDNA) mutant cells that harbor human disease-associated oxidative phosphorylation defects. Stimulating this flux with αKG supplementation enables the survival of diverse mtDNA mutant cells under otherwise lethal obligatory oxidative conditions. Strikingly, we demonstrate that when residual mitochondrial respiration in mtDNA mutant cells exceeds 45% of control levels, αKG oxidative flux prevails over reductive carboxylation. Furthermore, in a mouse model of mitochondrial myopathy, we show that increased oxidative αKG flux in muscle arises from enhanced alanine synthesis and release into blood, concomitant with accelerated amino acid catabolism from protein breakdown. Importantly, in this mouse model of mitochondriopathy, muscle amino acid imbalance is normalized by αKG supplementation. Taken together, our findings provide a rationale for αKG supplementation as a therapeutic strategy for mitochondrial myopathies.

Indexed as

Ketoglutaric AcidsMitochondriaMitochondrial MyopathiesAdaptation, PhysiologicalAlanineAnimalsDisease Models, AnimalDNA, MitochondrialEnergy MetabolismGlutamineHeLa CellsHumansMaleMiceMutationOxidative PhosphorylationAlanineDNA, MitochondrialGlutamineKetoglutaric Acidsanaplerosisglutamateglutaminemetabolismmitochondriamitochondrial diseasesmyopathyOXPHOS dysfunctionskeletal muscleα-ketoglutarate

Identifiers

PMID29657030
PMCPMC5932217
OpenAlexW2797582589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.